These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 9570543

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
    Cruickshank MN, Fenwick E, Karimi M, Abraham LJ, Ulgiati D.
    Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A highly conserved c-fms gene intronic element controls macrophage-specific and regulated expression.
    Himes SR, Tagoh H, Goonetilleke N, Sasmono T, Oceandy D, Clark R, Bonifer C, Hume DA.
    J Leukoc Biol; 2001 Nov; 70(5):812-20. PubMed ID: 11698502
    [Abstract] [Full Text] [Related]

  • 7. Identification of 5'-regions affecting the expression of the human CR2 gene.
    Yang LM, Behrens M, Weis JJ.
    J Immunol; 1991 Oct 01; 147(7):2404-10. PubMed ID: 1833454
    [Abstract] [Full Text] [Related]

  • 8. Yin Yang 1, Oct1, and NFAT-4 form repeating, cyclosporin-sensitive regulatory modules within the murine CD21 intronic control region.
    Zabel MD, Wheeler W, Weis JJ, Weis JH.
    J Immunol; 2002 Apr 01; 168(7):3341-50. PubMed ID: 11907091
    [Abstract] [Full Text] [Related]

  • 9. Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene.
    Christensen SM, Martin BK, Tan SS, Weis JH.
    J Immunol; 1992 Jun 01; 148(11):3610-7. PubMed ID: 1534100
    [Abstract] [Full Text] [Related]

  • 10. [Human immunoglobulin heavy-chain gene intronic enhancer segment HE2 (microB) functions as a major B-cell specific cis-element at cellular level as well as in transgenic mice].
    Enjoji M.
    Fukuoka Igaku Zasshi; 1992 Jun 01; 83(6):262-74. PubMed ID: 1511952
    [Abstract] [Full Text] [Related]

  • 11. Transcriptional regulation of the complement receptor 2 gene: role of a heterogeneous nuclear ribonucleoprotein.
    Tolnay M, Lambris JD, Tsokos GC.
    J Immunol; 1997 Dec 01; 159(11):5492-501. PubMed ID: 9548489
    [Abstract] [Full Text] [Related]

  • 12. A 150-base pair 5' region of the MHC class I HLA-B7 gene is sufficient to direct tissue-specific expression and locus control region activity: the alpha site determines efficient expression and in vivo occupancy at multiple cis-active sites throughout this region.
    Kushida MM, Dey A, Zhang XL, Campbell J, Heeney M, Carlyle J, Ganguly S, Ozato K, Vasavada H, Chamberlain JW.
    J Immunol; 1997 Nov 15; 159(10):4913-29. PubMed ID: 9366417
    [Abstract] [Full Text] [Related]

  • 13. Differentiation-specific transcriptional regulation of the ESE-2 gene by a novel keratinocyte-restricted factor.
    Tummala R, Sinha S.
    J Cell Biochem; 2006 Mar 01; 97(4):766-81. PubMed ID: 16229011
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Functional dissection of the murine lck distal promoter.
    Wildin RS, Wang HU, Forbush KA, Perlmutter RM.
    J Immunol; 1995 Aug 01; 155(3):1286-95. PubMed ID: 7636195
    [Abstract] [Full Text] [Related]

  • 16. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D, Masri S, Ye JJ, Chen S.
    Gene; 2005 Nov 21; 361():89-100. PubMed ID: 16181749
    [Abstract] [Full Text] [Related]

  • 17. A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation.
    Makar KW, Ulgiati D, Hagman J, Holers VM.
    Int Immunol; 2001 May 21; 13(5):657-64. PubMed ID: 11312253
    [Abstract] [Full Text] [Related]

  • 18. Distinct stage-specific cis-active transcriptional mechanisms control expression of T cell coreceptor CD8 alpha at double- and single-positive stages of thymic development.
    Zhang XL, Seong R, Piracha R, Larijani M, Heeney M, Parnes JR, Chamberlain JW.
    J Immunol; 1998 Sep 01; 161(5):2254-66. PubMed ID: 9725219
    [Abstract] [Full Text] [Related]

  • 19. The 14.1 surrogate light chain promoter has lineage- and stage-restricted activity.
    Donohoe ME, Blomberg BB.
    J Immunol; 1997 Feb 15; 158(4):1681-91. PubMed ID: 9029104
    [Abstract] [Full Text] [Related]

  • 20. Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells.
    Kwon DN, Choi YJ, Park JY, Cho SK, Kim MO, Lee HT, Kim JH.
    J Cell Biochem; 2006 Oct 01; 99(2):462-77. PubMed ID: 16619260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.